Isolation of Novel Compounds Involved in RPE Atrophy
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2005 - March 31, 2007
Grant ID
M2005008
Summary
AMD is a disease in which the macula, the central part of the retina of the eye, loses cells that cannot be replaced. This cellular damage is believed to be responsible for the loss of vision. The primary goal of Dr. Vollmer-Snarr’s research efforts is to more completely identify the specific chemical components of the macula that are being damaged and may cause AMD. The chemical composition of the macula strongly suggests that unknown compounds related to the known damaging agent are present. These other components may provide a missing link in our understanding of AMD and other macular diseases. The long-term objective of this project is to provide new insight in order to develop preventative and therapeutic strategies for AMD and other retinal degenerative diseases.
Grants
Related Grants
Macular Degeneration Research
Addressing the Link Between Impairment in Phagosome Degradation and AMD
Active Dates
July 01, 2021 - November 30, 2023
Principal Investigator
Antonio Escudero Paniagua, PhD
Addressing the Link Between Impairment in Phagosome Degradation and AMD
Active Dates
July 01, 2021 - November 30, 2023
Principal Investigator
Antonio Escudero Paniagua, PhD
Macular Degeneration Research
Novel Antibody-Based Agonist for Neovascular AMD
Active Dates
July 01, 2021 - June 30, 2023
Principal Investigator
Rony Chidiac, PhD
Novel Antibody-Based Agonist for Neovascular AMD
Active Dates
July 01, 2021 - June 30, 2023
Principal Investigator
Rony Chidiac, PhD
Macular Degeneration Research
A New Animal Model of Severe Age-Related Macular Degeneration
Active Dates
July 01, 2021 - June 30, 2024
Principal Investigator
Brittany Carr, PhD
A New Animal Model of Severe Age-Related Macular Degeneration
Active Dates
July 01, 2021 - June 30, 2024
Principal Investigator
Brittany Carr, PhD